- Country: Belgium
- Summary: Antitumor Drugs
- BET Ref No: 102875459
- Deadline: 25 Jul 2024
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: Refer Document
- Notice Type: Tender
- Document Ref. No.: 363336-2024
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- Antitumoraux
Bendamustine injectable
Fluorouracil injectable
Gemcitabine injectable
Vinorelbine injectable
Etoposide injectable
Paclitaxel injectable
Docetaxel injectable
Topotecan injectable
Irinotecan injectable
Trabectedine injectable
Doxorubicine injectable
Epirubicine injectable
Cisplatine - Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINAntitumor Drugs - Belgium Tender
The CHIREC, a Government sector organization in Belgium, has announced a new tender for Antitumor Drugs. This tender is published on BelgiumTenders under BET Ref No: 102875459 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2024-07-25.
The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
